Ambrose Healthcare fortifies rare disease pipeline on AM-Pharma takeover
Published . Updated .
Ambrose Healthcare fortifies rare disease pipeline on AM-Pharma takeover Pharmaceutical Technology
Directly affected
- No company is named in this report.
Indirectly affected
- XOM Exxon Mobil
Oil producers earn more when crude prices rise
- CVX Chevron
Oil producers earn more when crude prices rise
- OXY Occidental Petroleum
Oil producers earn more when crude prices rise
- COP ConocoPhillips
Oil producers earn more when crude prices rise
- XLV Health Care Select Sector SPDR
A fund of health-care companies
- XBI SPDR S&P Biotech
A fund of biotechnology companies
- VLO Valero
Refiners' profits move with crude and fuel prices
- MPC Marathon Petroleum
Refiners' profits move with crude and fuel prices
- XOP SPDR S&P Oil & Gas Exploration
A fund of oil and gas producers
- XLE Energy Select Sector SPDR
A fund of energy companies
Price reaction, T-5 to T+3
Ambrose Healthcare fortifies rare disease pipeline on AM-Pharma takeover Pharmaceutical Technology
Source: Pharmaceutical Technology
How solid the energy case looks
12 out of 100
“Ambrose Healthcare fortifies rare disease pipeline on AM-Pharma takeover” scores 12 out of 100. The score uses 1 sources.